Cargando…

National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study

OBJECTIVES: Treatment success rate in patients treated for multidrug-resistant tuberculosis (MDR-TB) is low, but predictors of treatment failure and death have been under-reported. Thus, we aimed to determine the national proportion of treatment success rate in the past 10 years and factors that pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tola, Habteyes, Holakouie-Naieni, K, Mansournia, Mohammad Ali, Yaseri, Mehdi, Gamtesa, Dinka Fikadu, Tesfaye, Ephrem, Mahamed, Zemedu, Sisay, Million Molla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356165/
https://www.ncbi.nlm.nih.gov/pubmed/34376436
http://dx.doi.org/10.1136/bmjopen-2020-040862
_version_ 1783736894943657984
author Tola, Habteyes
Holakouie-Naieni, K
Mansournia, Mohammad Ali
Yaseri, Mehdi
Gamtesa, Dinka Fikadu
Tesfaye, Ephrem
Mahamed, Zemedu
Sisay, Million Molla
author_facet Tola, Habteyes
Holakouie-Naieni, K
Mansournia, Mohammad Ali
Yaseri, Mehdi
Gamtesa, Dinka Fikadu
Tesfaye, Ephrem
Mahamed, Zemedu
Sisay, Million Molla
author_sort Tola, Habteyes
collection PubMed
description OBJECTIVES: Treatment success rate in patients treated for multidrug-resistant tuberculosis (MDR-TB) is low, but predictors of treatment failure and death have been under-reported. Thus, we aimed to determine the national proportion of treatment success rate in the past 10 years and factors that predict treatment failure and death in patients with MDR-TB in Ethiopia. SETTING: A retrospective cohort study with a 10-years follow-up period was conducted in 42 MDR-TB treatment-initiating centres in Ethiopia. PARTICIPANTS: A total of 3395 adult patients with MDR-TB who had final treatment outcome and who were treated under national TB programme were included. Data were collected from clinical charts, registration books and laboratory reports. Competing risk survival analysis model with robust standard errors (SE) was used to determine the predictors of treatment failure and death. PRIMARY AND SECONDARY OUTCOMES: Treatment outcome was a primary outcome whereas predictors of treatment failure and death were a secondary outcome. RESULTS: The proportion of treatment success was 75.7%, death rate was 12.8%, treatment failure was 1.7% and lost to follow-up was 9.7%. The significant predictors of death were older age (adjusted hazard ratio (AHR)=1.03; 95% CI 1.03 to 1.05; p<0.001), HIV infection (AHR=2.0; 95% CI 1.6 to 2.4; p<0.001) and presence of any grade of anaemia (AHR=1.7; 95% CI 1.4 to 2.0; p<0.001). Unlike the predictors of death, all variables included into multivariable model were not significantly associated with treatment failure. CONCLUSION: In the past 10 years, although MDR-TB treatment success in Ethiopia has been consistently favourable, the proportion of patients who died is still considerable. Death could be attributed to advanced age, HIV infection and anaemia. Prospective cohort studies are necessary to further explore the potentially modifiable predictors of treatment failure.
format Online
Article
Text
id pubmed-8356165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-83561652021-08-24 National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study Tola, Habteyes Holakouie-Naieni, K Mansournia, Mohammad Ali Yaseri, Mehdi Gamtesa, Dinka Fikadu Tesfaye, Ephrem Mahamed, Zemedu Sisay, Million Molla BMJ Open Infectious Diseases OBJECTIVES: Treatment success rate in patients treated for multidrug-resistant tuberculosis (MDR-TB) is low, but predictors of treatment failure and death have been under-reported. Thus, we aimed to determine the national proportion of treatment success rate in the past 10 years and factors that predict treatment failure and death in patients with MDR-TB in Ethiopia. SETTING: A retrospective cohort study with a 10-years follow-up period was conducted in 42 MDR-TB treatment-initiating centres in Ethiopia. PARTICIPANTS: A total of 3395 adult patients with MDR-TB who had final treatment outcome and who were treated under national TB programme were included. Data were collected from clinical charts, registration books and laboratory reports. Competing risk survival analysis model with robust standard errors (SE) was used to determine the predictors of treatment failure and death. PRIMARY AND SECONDARY OUTCOMES: Treatment outcome was a primary outcome whereas predictors of treatment failure and death were a secondary outcome. RESULTS: The proportion of treatment success was 75.7%, death rate was 12.8%, treatment failure was 1.7% and lost to follow-up was 9.7%. The significant predictors of death were older age (adjusted hazard ratio (AHR)=1.03; 95% CI 1.03 to 1.05; p<0.001), HIV infection (AHR=2.0; 95% CI 1.6 to 2.4; p<0.001) and presence of any grade of anaemia (AHR=1.7; 95% CI 1.4 to 2.0; p<0.001). Unlike the predictors of death, all variables included into multivariable model were not significantly associated with treatment failure. CONCLUSION: In the past 10 years, although MDR-TB treatment success in Ethiopia has been consistently favourable, the proportion of patients who died is still considerable. Death could be attributed to advanced age, HIV infection and anaemia. Prospective cohort studies are necessary to further explore the potentially modifiable predictors of treatment failure. BMJ Publishing Group 2021-08-10 /pmc/articles/PMC8356165/ /pubmed/34376436 http://dx.doi.org/10.1136/bmjopen-2020-040862 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Tola, Habteyes
Holakouie-Naieni, K
Mansournia, Mohammad Ali
Yaseri, Mehdi
Gamtesa, Dinka Fikadu
Tesfaye, Ephrem
Mahamed, Zemedu
Sisay, Million Molla
National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
title National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
title_full National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
title_fullStr National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
title_full_unstemmed National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
title_short National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
title_sort national treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in ethiopia: a 10-year retrospective cohort study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356165/
https://www.ncbi.nlm.nih.gov/pubmed/34376436
http://dx.doi.org/10.1136/bmjopen-2020-040862
work_keys_str_mv AT tolahabteyes nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy
AT holakouienaienik nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy
AT mansourniamohammadali nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy
AT yaserimehdi nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy
AT gamtesadinkafikadu nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy
AT tesfayeephrem nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy
AT mahamedzemedu nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy
AT sisaymillionmolla nationaltreatmentoutcomeandpredictorsofdeathandtreatmentfailureinmultidrugresistanttuberculosisinethiopiaa10yearretrospectivecohortstudy